Assay
Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| OptimizeRx Corp.OPRX · other | |
|---|---|
| Grade |  Astrongest fifth of 336 graded peers; percentile 15.5, sampling error 2.6 points; lower is stronger |
| Rank | 53 of 336 |
| Profitability | Cpercentile 56.7 |
| Solvency | A/Bpercentile 19.3 |
| Growth and financing | Bpercentile 29.0 |
| Reliability | 0.87 AUCfailure model, filers with $120M to $591M assets; 95% interval 0.83 to 0.90; 206 events, 2020 to 2025 |
| Peer failure rate | 1.03% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $120M to $591M assetstotal assets $176.9M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | none activenot computable: distress |
| Inputs computable | 12 of 14 |
| Graded from | filings received through Mar 12, 2026211 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $8.372026-10-08; market equity $157.6M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||||||||||||||||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Mar 12, 2026; the document on sec.gov.
OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care.
The Fourteen Inputs [top]
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 56.7 | |||||||
| Gross profitability | 41.6% | [1,3] | 27.1% | 25.0 | 289 | 2025-12-31 | |
| Return on invested capital | 6.4% | [4-12] | 10.0% | 64.7 | 151 | 2025-12-31 | |
| Accruals ratio | (7.8%) | [1,13-15] | (5.9%) | 37.6 | 506 | 2025-12-31 | |
| Gross margin stability, five years | 1495.7 pts | [2-3,16-23] | 2.2 pts | 99.5 | 204 | 2025-12-31 | |
| Solvency, sleeve percentile 19.3 | |||||||
| Twelve-month failure probability | not computable | 0.04% | |||||
| latest liabilities, cash plus short-term investments, book equity, and shares are required | |||||||
| Altman Z double-prime | 3.37 | [1,4,8,24-27] | 2.05 | 28.1 | 386 | 2025-12-31 | |
| Net debt to EBITDA | 0.25x | [4,7,9,28] | 2.52x | 14.2 | 184 | 2025-12-31 | |
| Interest coverage | not computable | 2.18x | |||||
| latest aligned inputs end 2023-12-31; latest annual assets end 2025-12-31 | |||||||
| Current ratio | 3.04x | [24-25] | 1.32x | 15.6 | 506 | 2025-12-31 | |
| Growth and financing, sleeve percentile 29.0 | |||||||
| Revenue growth, three-year compound | 374.4% | [2,17,19,21] | 5.1% | 0.0 | 403 | 2025-12-31 | |
| Free cash flow growth, three-year compound | 20.8% | [14,29-35] | 8.7% | 32.4 | 220 | 2025-12-31 | |
| Reinvestment rate | 93.7% | [4-6,24-25,28-29,36-37] | 11.9% | 17.5 | 190 | 2025-12-31 | |
| Asset growth, three years | 9.5% | [1,15,38-39] | 4.1% | 28.1 | 438 | 2025-12-31 | |
| Net share issuance, one year | 1.5% | [40-41] | (0.4%) | 67.0 | 356 | 2026-02-26 | |
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Sleeves are equal-weighted; within a sleeve each computable input carries equal weight. Composite -0.332; sampling error 2.6 percentile points on 336 peers.
Among 336 Peers [top]
Composite score of every graded peer, smoothed. Vertical rules are the letter band edges at the 20th, 40th, 60th and 80th percentiles. Small dots are the six largest peers by market equity.
| Rank | Company | Percentile | Letter | Warnings |
|---|---|---|---|---|
| 48 | Booz Allen Hamilton Holding Corp. (BAH) Booz Allen Hamilton Holding Corp. (BAH) Astrongest fifth; percentile 14.0 NYSE · Services-Management Consulting Services market equity $8.8B; last close $72.88 No active warnings; 12 of 14 inputs | 14.0 | A | |
| 49 | DoorDash, Inc. (DASH) DoorDash, Inc. (DASH) Astrongest fifth; percentile 14.3 Nasdaq · Services-Business Services, NEC last close $191.67 No active warnings; 7 of 14 inputs | 14.3 | A | |
| 50 | Champion Homes, Inc. (SKY) Champion Homes, Inc. (SKY) Astrongest fifth; percentile 14.6 NYSE · Mobile Homes market equity $4.4B; last close $81.59 Warnings: fortress balance sheet; 11 of 14 inputs | 14.6 | A | fortress balance sheet |
| 51 | Emcor Group, Inc. (EME) Emcor Group, Inc. (EME) Astrongest fifth; percentile 14.9 NYSE · Electrical Work market equity $34.3B; last close $777.80 Warnings: fortress balance sheet; 11 of 14 inputs | 14.9 | A | fortress balance sheet |
| 52 | Concentrix Corp. (CNXC) Concentrix Corp. (CNXC) Astrongest fifth; percentile 15.2 Nasdaq · Services-Business Services, NEC market equity $1.7B; last close $27.08 No active warnings; 10 of 14 inputs | 15.2 | A | |
| 53 | OptimizeRx Corp. (OPRX) OptimizeRx Corp. (OPRX) Astrongest fifth; percentile 15.5 Nasdaq · Services-Business Services, NEC market equity $157.8M; last close $8.37 No active warnings; 12 of 14 inputs | 15.5 | A | |
| 54 | Mercadolibre Inc. (MELI) Mercadolibre Inc. (MELI) Astrongest fifth; percentile 15.8 Nasdaq · Services-Business Services, NEC market equity $94.1B; last close $1,855.54 No active warnings; 11 of 14 inputs | 15.8 | A | |
| 55 | Expedia Group, Inc. (EXPE) Expedia Group, Inc. (EXPE) Astrongest fifth; percentile 16.1 Nasdaq · Transportation Services market equity $30.9B; last close $270.29 No active warnings; 9 of 14 inputs | 16.1 | A | |
| 56 | Madison Square Garden Entertainment Corp. (MSGE) Madison Square Garden Entertainment Corp. (MSGE) Astrongest fifth; percentile 16.4 NYSE · Services-Miscellaneous Amusement & Recreation last close $81.84 No active warnings; 7 of 14 inputs | 16.4 | A | |
| 57 | LAS Vegas Sands Corp. (LVS) LAS Vegas Sands Corp. (LVS) Astrongest fifth; percentile 16.7 NYSE · Hotels & Motels market equity $23.4B; last close $36.09 No active warnings; 8 of 14 inputs | 16.7 | A | |
| 58 | Tidewater Inc. (TDW) Tidewater Inc. (TDW) Astrongest fifth; percentile 17.0 NYSE · Water Transportation last close $84.59 No active warnings; 7 of 14 inputs | 17.0 | A |
| Peer policy | Letter | Percentile | Peers |
|---|---|---|---|
| all graded filers, equal sleeves | A | 17.0 | 2204 |
| sector peers, equal sleeves (the grade) | A | 15.5 | 336 |
| same exchange, equal sleeves | A/B | 19.5 | 1219 |
| sector peers, equal inputs | A | 13.7 | 336 |
Each letter is one fifth of the 336 graded peers, about 67 companies. A boundary letter (A/B, B/C, C/D, D/E) marks a percentile within one sampling error of a band edge.
What the Price Implies [top]
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | (61.1%) | 2.0% | 6 | hotter than 6 of 100 peers |
| Distance from 52-week high | (61.3%) | (26.8%) | 11 | closer to its high than 11 of 100 peers |
| EBIT to enterprise value | 7.6% | 4.4% | 78 | pricier than 22 of 100 peers |
| Free cash flow yield | 11.8% | 4.1% | 87 | pricier than 13 of 100 peers |
| Book value to price | 0.83 | 0.34 | 80 | pricier than 20 of 100 peers |
| Sales to price | 0.69 | 0.70 | 49 | pricier than 51 of 100 peers |
| Composite equity issuance, five years | 11.4% | (8.8%) | 78 | more equity-funded than 78 of 100 peers |
| Relative strength against the sector, log excess return | (1.09) | (0.13) | 6 | ahead of 6 of 100 peers |
Inputs: market equity $157.8M; EBIT $11.7M; free cash flow $18.7M; book equity $131.1M; sales $109.4M; debt $19.7M; cash $24.1M[42].
Diagnostics [top]
Diagnostics do not feed the grade.
| Piotroski F-score: 8 of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | 3.0% | ✓ pass[13,15] |
| Operating cash flow above zero | $18.7M | ✓ pass[14] |
| Return on assets improved | 14.0 pts | ✓ pass[13,15,38,43] |
| Operating cash flow exceeds net income | $13.6M | ✓ pass[13-14] |
| Long-term leverage fell | (5.1 pts) | ✓ pass[1,15,38,44-45] |
| Current ratio improved | 15.0 pts | ✓ pass[24-25,36-37] |
| No new shares issued | 1.5% | ✗ fail[40-41] |
| Gross margin improved | 2.8 pts | ✓ pass[2-3,16-17] |
| Asset turnover improved | 13.7 pts | ✓ pass[2,15,17,38] |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $24.1M[46] |
| Operating cash flow, four quarters | $18.4M[14,46-50] |
| Months of runway | not finite |
| trailing operating cash flow is nonnegative, so runway is not finite | |
| Late filings, two years | 0 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 57 |
| 10-Q received Aug 13, 2026 | |
| Median daily dollar volume | $1.5M |
| 63 sessions | |
| Days since newest grade input | 211 |
Downloads [top]
|
Sources [top]
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $176.9M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $109.4M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 3 | gross profit | us-gaap:GrossProfit | $73.6M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 4 | operating income | us-gaap:OperatingIncomeLoss | $11.7M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 5 | pretax income | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $7.0M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 6 | income tax | us-gaap:IncomeTaxExpenseBenefit | $1.8M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 7 | total debt | us-gaap:LongTermDebt | $26.3M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 8 | book equity | us-gaap:StockholdersEquity | $128.3M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 9 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $23.4M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 10 | total debt | us-gaap:LongTermDebt | $34.3M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 11 | book equity | us-gaap:StockholdersEquity | $117.0M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 12 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $13.4M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 13 | net income | us-gaap:NetIncomeLoss | $5.1M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 14 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $18.7M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 15 | assets | us-gaap:Assets | $171.2M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 16 | gross profit | us-gaap:GrossProfit | $59.4M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 17 | revenue | us-gaap:Revenues | $92.1M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 18 | gross profit | us-gaap:GrossProfit | $42.9M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 19 | revenue | us-gaap:Revenues | $71.5M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 20 | gross profit | us-gaap:GrossProfit | $39.0M | 2022-12-31 | 2024-04-15 | 10-K | filing · viewer · series |
| 21 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $1.0M | 2022-12-31 | 2023-03-10 | 10-K | filing · viewer · series |
| 22 | gross profit | us-gaap:GrossProfit | $35.6M | 2021-12-31 | 2023-03-10 | 10-K | filing · viewer · series |
| 23 | revenue | us-gaap:Revenues | $61.3M | 2021-12-31 | 2023-03-10 | 10-K | filing · viewer · series |
| 24 | current assets | us-gaap:AssetsCurrent | $64.7M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 25 | current liabilities | us-gaap:LiabilitiesCurrent | $21.3M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 26 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$79.2M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 27 | liabilities | us-gaap:Liabilities | $48.6M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 28 | depreciation amortization | us-gaap:Depreciation | $102,000 | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 29 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $58,000 | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 30 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $4.9M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 31 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $112,000 | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 32 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$7.2M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 33 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $87,000 | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 34 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $10.7M | 2022-12-31 | 2024-04-15 | 10-K | filing · viewer · series |
| 35 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $81,005 | 2022-12-31 | 2024-04-15 | 10-K | filing · viewer · series |
| 36 | current assets | us-gaap:AssetsCurrent | $54.0M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 37 | current liabilities | us-gaap:LiabilitiesCurrent | $18.7M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 38 | assets | us-gaap:Assets | $183.4M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 39 | assets | us-gaap:Assets | $134.7M | 2022-12-31 | 2024-04-15 | 10-K | filing · viewer · series |
| 40 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 18,762,203 | 2026-02-26 | 2026-03-12 | 10-K | filing · viewer · series |
| 41 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 18,490,385 | 2025-03-11 | 2025-03-20 | 10-K | filing · viewer · series |
| 42 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 18,835,951 | 2026-07-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 43 | net income | us-gaap:NetIncomeLoss | -$20.1M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 44 | long term debt | us-gaap:LongTermDebtNoncurrent | $21.4M | 2025-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 45 | long term debt | us-gaap:LongTermDebtNoncurrent | $30.8M | 2024-12-31 | 2026-03-12 | 10-K | filing · viewer · series |
| 46 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $24.1M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 47 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $8.1M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 48 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$467,000 | 2026-03-31 | 2026-05-13 | 10-Q | filing · viewer · series |
| 49 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $11.6M | 2025-09-30 | 2025-11-07 | 10-Q | filing · viewer · series |
| 50 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $8.4M | 2025-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
Limitations [top]
Grade boundary. Percentile 15.5 is 4.5 points from the nearest band edge; sampling error is 2.6 points.
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
